AMIKACIN SULFATE
Generic: AMIKACIN SULFATE
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
AMIKACIN SULFATEActive Substance
1994-04-11Original Approval
AMIKACIN SULFATE is FDA application ANDA063315, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
PYREXIA
172 reports
2
OFF LABEL USE
150 reports
3
DRUG INEFFECTIVE
147 reports
4
NAUSEA
97 reports
5
PNEUMONIA
93 reports
6
SEPSIS
85 reports
7
CONDITION AGGRAVATED
84 reports
8
DYSPNOEA
82 reports
9
DIARRHOEA
78 reports
10
VOMITING
73 reports